Aimovig

Aimovig Warnings and Precautions

• Hypersensitivity reactions: Rash, angioedema, and anaphylaxis have been reported, occurring anywhere from hours to over a week after a dose. Discontinue and seek medical care if a serious reaction occurs.
• Severe constipation: Constipation has occasionally been severe enough to require hospitalization or surgery. Patients should be monitored and managed accordingly.
• Hypertension: New or worsening high blood pressure can occur, typically within a week of dosing. Blood pressure should be monitored.
• Raynaud's phenomenon: New onset or worsening of this circulation disorder has been reported. Treatment should be discontinued and evaluated if symptoms appear.

How to Access Aimovig in India: A 6-Step Process

Step 1 – Search & request your medicine: The patient or treating doctor submits a request with basic details to initiate the access process.

Step 2 – Verification & eligibility review: The team verifies availability and reviews eligibility against regulatory and clinical requirements to ensure a compliant pathway.

Step 3 – Receive quote & delivery timeline: A transparent quotation is shared, covering medicine cost, logistics, and a clear delivery timeline.

Step 4 – Regulatory approval process: Assistance is provided to secure the approvals and documentation required for legal cross-border access.

Step 5 – Temperature-controlled import & handling: The medicine is sourced and transported under strict GDP-compliant, cold-chain conditions to maintain product integrity.

Step 6 – Secure delivery: The medicine is delivered to the patient or treating hospital, with updates provided at each stage.

Note: From request to delivery, every step is designed to ensure your treatment reaches you safely, compliantly, and without unnecessary delays.

Documentation & Availability

What documents are required to import Aimovig to India?

Aimovig (erenumab-aooe) injection may be imported in the patient's name only, by patients or government hospitals, in line with India's import regulations for unapproved medicines. The following documentation is required:

• A valid prescription from a qualified doctor
• The patient's diagnostic reports and migraine history
• Patient ID proof (issued by the Government of India)

How is the order confirmed?

The order is confirmed only after receipt and verification of a valid prescription from the doctor and, if applicable, an import permit.

Is Aimovig available in India?

Aimovig (erenumab-aooe injection) is a prescription medicine that legally requires a doctor's prescription to be dispensed. As of current publicly available information, Aimovig is not commercially marketed in India.

However, patients in India can legally access Aimovig through the Named Patient Program (NPP) — an import provision that allows a medicine not yet registered in India to be imported in the name of a specific patient for their personal treatment, under a valid prescription.

Aimovig received US FDA approval in 2018, ensuring full transparency throughout the process.

Aimovig can be made available to patients, doctors, and hospitals across major cities in India, including Gurgaon, Delhi, Bangalore, Mumbai, Navi Mumbai, Thane, Hyderabad, Mysore, Kerala, Chennai, Coimbatore, Madurai, Kolkata, Ahmedabad, Surat, Vadodara, Pune, Nagpur, Nashik, Jaipur, Udaipur, Lucknow, Kanpur, Gorakhpur, Chandigarh, Mohali, Faridabad, Noida, Ghaziabad, Kochi, Trivandrum, Kozhikode, Thrissur, Kannur, Mangalore, Bhubaneswar, Patna, Ranchi, Raipur, Guwahati, Visakhapatnam, Vijayawada, Goa, Jammu, Srinagar, Dehradun, Bhopal, Indore, Ludhiana, Amritsar, and others — and can facilitate delivery to the patient's treating hospital. Orders are confirmed only after receipt of a valid doctor's prescription and an import permit, where applicable.

NPP also facilitates access to other CGRP-targeted migraine prevention therapies, including Ajovy (fremanezumab), for patients whose treating neurologist considers these options relevant to their case.

Sourcing & Delivery

NamedPatientProgram.com (NPP) can source Aimovig from reliable global channels and facilitate supply to patients, doctors, and hospitals under applicable legal provisions. As a temperature-sensitive biologic, Aimovig requires cold-chain handling throughout transit and must be kept refrigerated between 2°C to 8°C, protected from light, and never frozen. All prescriptions are dispensed and checked by registered pharmacists and dispatched from New Delhi, India, after legal requirements are fulfilled.

For Aimovig cost in India and availability, contact NPP via WhatsApp at +91 98104 69557 | Toll-Free: 1800-1200-365 or email info@namedpatientprogram.com.

Availability of Aimovig Across Major Cities in India

Patients across India can access Aimovig through regulated import pathways, with delivery arranged to the patient or treating hospital based on a valid neurologist's prescription.

Mumbai

A major healthcare hub with leading neurology centers, Mumbai coordinates access to advanced migraine prevention therapies like Aimovig.

Delhi

As part of the Delhi NCR region, the city has a strong concentration of neurology specialists, making it a key location for accessing CGRP-targeted migraine treatments.

Bangalore

With a growing network of multispecialty hospitals, Bangalore supports access to Aimovig through structured import pathways guided by treating specialists.

Chennai

Home to several reputed neurology practices, Chennai facilitates access to Aimovig for patients with chronic or episodic migraine.

Hyderabad

A growing hub for specialty care, Hyderabad supports coordinated access to Aimovig for eligible patients under specialist supervision.

Kolkata

Eastern India's leading medical centers in Kolkata coordinate Aimovig access for patients with migraine.

Pune

With an expanding base of neurology clinics, Pune facilitates timely access to Aimovig under prescription.

Ahmedabad

Gujarat's leading hospitals support regulated access to Aimovig for eligible patients.

Kochi

Kerala's healthcare network, including major hospitals in Kochi, coordinates access to advanced biologics like Aimovig.

Chandigarh

Serving North India, Chandigarh's specialist centers facilitate access to Aimovig for patients from Punjab, Haryana, and Himachal Pradesh.

Jaipur

Rajasthan's leading hospitals support patient access to Aimovig through the Named Patient Program.

Lucknow

A key referral center for North India, Lucknow facilitates coordinated access to Aimovig under specialist care.

Bhubaneswar

Odisha's growing specialty healthcare sector supports patient access to Aimovig.

Guwahati

As a referral hub for the North-East, Guwahati facilitates access to Aimovig for patients across the region.

Access can also be coordinated for patients in other major Indian cities, subject to a valid prescription and regulatory requirements.